SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583648-22-000051
Filing Date
2022-06-24
Accepted
2022-06-24 19:03:25
Documents
3
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165611178802913.html 4  
1 FORM 4 wf-form4_165611178802913.xml 4 3977
2 POA (PETER KIENER HTM) pieris-section16poapeter.htm EX-24 4014
3 POA (PETER KIENER JPG) pieris-section16poapeter001.jpg GRAPHIC 208089
  Complete submission text file 0001583648-22-000051.txt   296150
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address
Kiener Peter A (Reporting) CIK: 0001328146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 221041312

Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations